Hysteroscopic Findings in Women Using Progesterone Only Pills (Minipills)
NCT05024604 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2021-08-27
Summary
Hysteroscopic findings in women using progesterone only pills (minipills) :A Prospective cohort study.
Conditions
- Women Health
- Contraception
Interventions
- DRUG
-
Progesterone Only Product in Oral Dose Form
mini pills as a contraceptive method
- OTHER
-
office hysterscopy
office hysteroscoy
Sponsors & Collaborators
-
Samuel Gendy
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2022-09-01
- Completion
- 2022-12-05
Countries
- Egypt
Study Locations
More Related Trials
-
Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
NCT01499602 ·Status: COMPLETED ·Phase: NA
-
Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia
NCT03992937 ·Status: COMPLETED ·Phase: NA
-
Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level
NCT05742503 ·Status: COMPLETED
-
Endometrial Biopsy in Progestin Contraceptive Users
NCT05760144 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Female Sexual Functions With Progestogen-only Contraception
NCT02579590 ·Status: COMPLETED
-
Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
NCT02353247 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Contraceptive Efficacy
NCT06689150 ·Status: COMPLETED ·Phase: NA
-
Genistein and Endometrial Hyperplasia
NCT00453960 ·Status: COMPLETED ·Phase: PHASE2
-
Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers
NCT00377923 ·Status: COMPLETED ·Phase: PHASE1
-
Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
NCT01103518 ·Status: UNKNOWN ·Phase: PHASE4
-
Progesterone in Luteal Phase Deficiency
NCT02950948 ·Status: WITHDRAWN ·Phase: PHASE3
-
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
NCT07229209 ·Status: COMPLETED ·Phase: NA
-
Lower Dose Depo Provera® Contraceptive Injection
NCT02732418 ·Status: COMPLETED ·Phase: PHASE1
-
Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
NCT01776203 ·Status: TERMINATED ·Phase: PHASE4
-
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients
NCT05505435 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
NCT00212342 ·Status: COMPLETED ·Phase: PHASE3
-
Norethindrone for the Delay of Menstruation
NCT03594604 ·Status: COMPLETED ·Phase: PHASE4
-
Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy
NCT05586724 ·Status: RECRUITING ·Phase: PHASE3
-
The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding
NCT02326922 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood Clots
NCT00580424 ·Status: TERMINATED ·Phase: NA
-
Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
NCT00350480 ·Status: COMPLETED ·Phase: NA
-
Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study
NCT01176175 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study Into the Contraceptive Effect of Estetrol
NCT00563472 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Female Reproductive Hormone Dynamics During Adolescence
NCT02486757 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
NCT00770887 ·Status: COMPLETED